Opportunity Information: Apply for RFA 623 12 000008
Apply for RFA 623 12 000008
- The Kenya USAID Nairobi in the health sector is offering a public funding opportunity titled "National Tuberculosis and Leprosy Control Program (NTLP)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Aug 31, 2012 and posted on Aug 7, 2012.
- Applicants must submit their applications by Sep 13, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $12,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Tuberculosis and Leprosy Control Program (NTLP) grant opportunity is a USAID/Uganda-funded, five-year cooperative agreement designed to provide sustained technical assistance to Uganda's National TB and Leprosy Control Program. It sits under USAID/Uganda Development Objective 3, which focuses on improving health and nutritional status in priority areas and populations. The core purpose of the program is to help Uganda reach national targets for tuberculosis control by raising TB case detection rates and improving treatment success rates, while also reducing the overall burden of TB, multidrug-resistant TB (MDR-TB), and TB/HIV co-infection. The work is intended to concentrate on Kampala and on districts where USAID already supports TB programming, with an emphasis on strengthening systems and introducing practical, innovative approaches that can be scaled and sustained.
The activity is structured around four main implementation areas. First, it aims to strengthen the NTLP's leadership and technical capacity so the program can more effectively plan, manage, monitor, and implement TB control activities nationwide. This includes improving the NTLP's ability to guide policy and technical strategy, oversee performance, and ensure quality and consistency across district-level services. Second, it prioritizes expansion of community-based DOTS (Directly Observed Treatment, Short-course) in Kampala, recognizing that urban settings often face high patient mobility and barriers to consistent treatment adherence. The goal of the Kampala-focused effort is specifically to reduce treatment defaulting and improve outcomes through community follow-up and support mechanisms that make it easier for patients to complete therapy.
Third, the opportunity calls for scaling up the management of MDR-TB in selected districts to prevent further emergence and transmission of drug-resistant strains. This implies support for improved detection, appropriate referral and enrollment into MDR-TB care, and strengthening the quality of clinical and programmatic management needed for longer, more complex treatment regimens. Fourth, the program is expected to provide technical assistance to, and improve coordination among, USAID-supported partners operating at district level. The intent is to ensure that partner activities align with national NTLP guidelines, policies, and targets, and that DOTS, TB/HIV collaborative services, and community-based MDR-TB interventions are implemented in a consistent, harmonized way across USAID-supported geographies.
USAID lists several expected results by the end of the five-year period. These include stronger NTLP leadership and technical capacity for planning, monitoring, and implementation; a functional urban DOTS model in Kampala that uses community-based DOTS and improves treatment success, with a target treatment success rate of 85 percent by project end; implementation of a high-quality program for MDR-TB management; and improved coordination and implementation across DOTS, TB/HIV, and community-based MDR-TB interventions within USAID TB programs. In practical terms, the grant is designed not only to improve direct TB service outcomes, but also to leave behind a more capable national program and a better-aligned network of implementing partners working from a common national playbook.
From an administrative standpoint, the opportunity was posted as Funding Opportunity Number RFA 623-12-000008, with one award anticipated. The funding instrument is a cooperative agreement, meaning USAID expects substantial involvement during implementation rather than a fully hands-off grant. The award size is substantial, with an estimated floor of $10,000,000 and a ceiling of $12,500,000, and there is no cost-sharing or matching requirement. Eligibility is described as unrestricted (open to any type of entity, subject to any clarifications in the full announcement). The posting date was August 7, 2012, with a closing date of September 13, 2012, and the opportunity was archived October 13, 2012. The listing references USAID Nairobi (Kenya) in the agency field, while the program description clearly indicates implementation support for USAID/Uganda and the Uganda NTLP. A contact for access issues is provided: Margaret Rukwaro, Regional Acquisition and Assistance Specialist, at phone number 254208622481.
FAQs: National Tuberculosis and Leprosy Control Program (NTLP) Cooperative Agreement (USAID/Uganda)
1) What is this grant opportunity?
This is a USAID/Uganda-funded, five-year cooperative agreement designed to provide sustained technical assistance to Uganda's National Tuberculosis and Leprosy Control Program (NTLP). The overall intent is to help Uganda meet national tuberculosis (TB) control targets by improving TB case detection and treatment success, while reducing the burden of TB, multidrug-resistant TB (MDR-TB), and TB/HIV co-infection.
2) What is the official Funding Opportunity Number?
The Funding Opportunity Number listed is RFA 623-12-000008.
3) What type of funding instrument is being used?
The opportunity uses a cooperative agreement. This means USAID anticipates substantial involvement during implementation (rather than a fully hands-off grant relationship).
4) How long is the program period?
The activity is described as a five-year cooperative agreement.
5) How many awards does USAID anticipate making?
USAID anticipates one award.
6) What is the estimated funding amount?
The estimated funding floor is $10,000,000 and the estimated ceiling is $12,500,000.
7) Is there a cost-sharing or matching requirement?
No. The opportunity states there is no cost-sharing or matching requirement.
8) Who is eligible to apply?
Eligibility is described as unrestricted, meaning it is open to any type of entity, subject to any clarifications in the full announcement.
9) What USAID objective does this activity support?
The activity sits under USAID/Uganda Development Objective 3, which focuses on improving health and nutritional status in priority areas and populations.
10) What are the main goals of the program?
The core goals are to raise TB case detection rates, improve treatment success rates, and reduce the overall burden of TB, MDR-TB, and TB/HIV co-infection in Uganda.
11) Where will the work be concentrated geographically?
The work is intended to concentrate on Kampala and on districts where USAID already supports TB programming.
12) What approach does the opportunity emphasize?
The opportunity emphasizes strengthening systems and introducing practical, innovative approaches that can be scaled and sustained.
13) What are the four main implementation areas?
The activity is structured around four areas: (1) strengthening NTLP leadership and technical capacity; (2) expanding community-based DOTS in Kampala; (3) scaling up MDR-TB management in selected districts; and (4) providing technical assistance to and improving coordination among USAID-supported district-level partners.
14) What does "strengthening NTLP leadership and technical capacity" include?
It includes improving the NTLP's ability to plan, manage, monitor, and implement TB control activities nationwide, guide policy and technical strategy, oversee performance, and ensure quality and consistency across district-level services.
15) What is DOTS, as referenced in the opportunity?
DOTS refers to Directly Observed Treatment, Short-course. In this opportunity, DOTS is discussed in the context of improving adherence and treatment completion through community-based support.
16) Why is Kampala specifically emphasized for community-based DOTS expansion?
The opportunity notes that urban settings like Kampala often face high patient mobility and barriers to consistent treatment adherence. The Kampala-focused effort aims to reduce treatment defaulting and improve outcomes through community follow-up and support mechanisms.
17) What treatment success target is mentioned for Kampala's urban DOTS model?
The expected results include a target treatment success rate of 85 percent by the end of the project period, tied to a functional urban DOTS model in Kampala using community-based DOTS.
18) What is MDR-TB, and how does the opportunity address it?
MDR-TB refers to multidrug-resistant tuberculosis. The opportunity calls for scaling up management of MDR-TB in selected districts to prevent further emergence and transmission, implying support for improved detection, appropriate referral and enrollment into care, and strengthened quality of clinical and programmatic management for longer, more complex regimens.
19) What does the opportunity say about TB/HIV co-infection?
Reducing the burden of TB/HIV co-infection is explicitly included among the core purpose outcomes, and coordination is expected across DOTS, TB/HIV collaborative services, and community-based MDR-TB interventions in USAID-supported geographies.
20) What role does partner coordination play in this activity?
A key implementation area is to provide technical assistance to and improve coordination among USAID-supported district-level partners. The intent is to align partner activities with national NTLP guidelines, policies, and targets and to implement services in a consistent, harmonized way across USAID-supported areas.
21) What expected results are listed for the end of the five-year period?
Expected results include: stronger NTLP leadership and technical capacity for planning, monitoring, and implementation; a functional urban DOTS model in Kampala that improves treatment success (targeting 85 percent); implementation of a high-quality MDR-TB management program; and improved coordination and implementation across DOTS, TB/HIV, and community-based MDR-TB interventions within USAID TB programs.
22) Is this activity focused only on direct service delivery?
The description indicates the grant is designed to improve direct TB service outcomes and also to leave behind a more capable national program and a better-aligned network of implementing partners working from a common national approach.
23) When was the opportunity posted and when did it close?
The posting date is August 7, 2012, and the closing date is September 13, 2012.
24) What does it mean that the opportunity is archived?
The listing states the opportunity was archived on October 13, 2012, which indicates it is no longer an active, open solicitation in that listing.
25) Which USAID office is referenced in the listing?
The agency field references USAID Nairobi (Kenya), while the program description indicates implementation support for USAID/Uganda and Uganda's NTLP.
26) Who is the contact person listed for access issues, and how can they be reached?
The contact for access issues is Margaret Rukwaro, Regional Acquisition and Assistance Specialist, at phone number 254208622481.
Browse more opportunities from the same agency: Kenya USAID Nairobi
Browse more opportunities from the same category: Health
Next opportunity: 2013 NIH Directors Pioneer Award Program (DP1)
Previous opportunity: Womens Hertiage Intitiative
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 623 12 000008
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 623 12 000008) also looked into and applied for these:
| Funding Opportunity |
|---|
| 2013 NIH Directors Pioneer Award Program (DP1) Apply for RFA RM 12 015 Funding Number: RFA RM 12 015 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| 2013 NIH Directors New Innovator Award Program (DP2) Apply for RFA RM 12 016 Funding Number: RFA RM 12 016 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Development and Application of Systems Approaches for Analyzing the Impact of Genomic Variation on Tissue Transcriptomes (R01) Apply for RFA RM 12 019 Funding Number: RFA RM 12 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Grants for Health Services Research Dissertation Program (R36) Apply for PA 12 256 Funding Number: PA 12 256 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| AHRQ Individual Awards for Postdoctoral Fellows (F32) National Research Service Awards (NRSA) Apply for PA 12 261 Funding Number: PA 12 261 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Tribal Self Governance Program Planning Cooperative Agreement Apply for HHS 2012 IHS TSGP 0001 Funding Number: HHS 2012 IHS TSGP 0001 Agency: Indian Health Service Category: Health Funding Amount: $120,000 |
| Limited Competition NIMHD Community Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities Dissemination Phase (R24) Apply for RFA MD 13 001 Funding Number: RFA MD 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $375,000 |
| NIMH Short Courses for Mental Health Related Research Education (R25) Apply for PAR 12 262 Funding Number: PAR 12 262 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIMH Research Education Programs Supporting Psychiatric Residents (R25) Apply for PAR 12 263 Funding Number: PAR 12 263 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIMH Mentoring Networks for Mental Health Research Education (R25) Apply for PAR 12 264 Funding Number: PAR 12 264 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Limited Competition Pregnancy as a Window to Future Cardiovascular Health Adverse Pregnancy Outcomes as Predictors of Increased Risk Factors for Cardiovascular Disease (U10) Apply for RFA HL 13 014 Funding Number: RFA HL 13 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Health Network Development Planning Program Apply for HRSA 13 153 Funding Number: HRSA 13 153 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Molecular Mechanisms of Circadian Clocks in Aging Tissues (R01) Apply for RFA AG 13 007 Funding Number: RFA AG 13 007 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analyses of CALERIE Data Set and Stored Biospecimens to Address Research Questions Related to Effects of Caloric Restriction in Humans and Adherence to Caloric Restriction Interventions (R01) Apply for RFA AG 13 008 Funding Number: RFA AG 13 008 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| National Indian Health Outreach and Education Apply for HHS 2012 IHS NIHOE 0001 Funding Number: HHS 2012 IHS NIHOE 0001 Agency: Indian Health Service Category: Health Funding Amount: $966,000 |
| National Indian Health Outreach and Education Apply for HHS 2012 IHS NIHOE 0003 Funding Number: HHS 2012 IHS NIHOE 0003 Agency: Indian Health Service Category: Health Funding Amount: $600,000 |
| Human Heredity and Health in Africa (H3Africa) H3Africa Biorepository Grants. (UH2/UH3) Apply for RFA RM 12 008 Funding Number: RFA RM 12 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Healthy Tomorrows Partnership for Children Program (HTPCP) Apply for HRSA 13 176 Funding Number: HRSA 13 176 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Tobacco Control Regulatory Research R21 Apply for PAR 12 266 Funding Number: PAR 12 266 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Tobacco Control Regulatory Research R01 Apply for PAR 12 267 Funding Number: PAR 12 267 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 623 12 000008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.